Literature DB >> 2865685

Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

E N Juberg, K P Minneman, P W Abel.   

Abstract

The properties of beta 1- and beta 2-adrenoceptors in right and left atria of rat heart, and their roles in mediating chronotropic and inotropic responses to beta-adrenoceptor agonists were examined. [125I](-)pindolol (125IPIN) bound saturably and specifically to a single class of high affinity sites in homogenates of both right and left atria. The k1's for association in right and left atria were 6.5 X 10(9) l/mol-min and 2.3 X 10(9) l/mol-min respectively, while the k-1's for dissociation were 0.20 min-1 and 0.17 min-1. The kinetically determined KD's were 75 pmol/l in right and 30 pmol/l in left atria and were similar to the equilibrium KD's determined from Scatchard analysis of saturation isotherms of specific 125IPIN binding. Inhibition of 125IPIN binding by beta-adrenoceptor antagonists was stereoselective and the order of potency was timolol greater than l-propranolol greater than d-propranolol greater than sotalol. Inhibition by beta 1- and beta 2-adrenoceptor subtype selective antagonists yielded flat displacement curves with low Hill coefficients. Nonlinear regression analysis of displacement by beta 1-selective (practolol, atenolol and metoprolol) and beta 2-selective (ICI 118,551) antagonists gave estimates of the proportion of beta 1- and beta 2-adrenoceptors present in rat atria. Right atria contained 67 +/- 4.2% beta 1- and 33 +/- 4.2% beta 2-adrenoceptors, while left atria contained 67 +/- 2.8% beta 1- and 33 +/- 2.8% beta 2-adrenoceptors. Increases in the rate of spontaneously beating right atria and the force of electrically driven left atria caused by beta-adrenoceptor agonists were also measured. pA2 values for non-subtype selective beta-adrenoceptor antagonists in inhibiting isoprenaline-induced increases in rate and force were highly correlated with KD values determined for specific 125IPIN binding. pA2 values for beta 1- and beta 2-selective antagonists in inhibiting isoprenaline-induced increases in rate and force correlated well with the pKD values of these drugs in binding to beta 1-adrenoceptors, but not with the pKD values in binding to beta 2-adrenoceptors. Dose-response curves for stimulation of both rate and force by the beta 2-selective agonists procaterol and zinterol were shifted to a much greater extent by selective blockade of beta 1-adrenoceptors with metoprolol than by selective blockade of beta 2-adrenoceptors with ICI 118,551, suggesting that these compounds caused their effects by activating beta 1-adrenoceptors.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865685     DOI: 10.1007/bf00572434

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  Comparison of beta adrenergic receptor subtypes in mammalian tissues.

Authors:  K P Minneman; A Hedberg; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1979-12       Impact factor: 4.030

2.  Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart.

Authors:  A Hedberg; K P Minneman; P B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  1980-03       Impact factor: 4.030

3.  Direct evidence of two types of beta adrenoceptor binding site in lung tissue.

Authors:  D B Barnett; E L Rugg; S R Nahorski
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

4.  On equilibrium dissociation constants for complexes of drug-receptor subtypes. Selective and non-selective interactions of partial agonists with two plausible beta-adrenoceptor subtypes mediating positive chronotropic effects of (-)-isoprenaline in kitten atria.

Authors:  A J Kaumann; M Marano
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

5.  beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo.

Authors:  J G Copeland; D F Larson; W R Roeske; D H Russell; J R Womble
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

6.  Dissociation constants of isoprenaline and orciprenaline and their relative efficacies on guinea-pig isolated atria determined by use of an irreversible beta-adrenoceptor antagonist.

Authors:  K J Broadley; C D Nicholson
Journal:  Br J Pharmacol       Date:  1981-04       Impact factor: 8.739

7.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

8.  Beta 2-adrenoceptors in guinea-pig atria.

Authors:  L H Johansson; H Persson
Journal:  J Pharm Pharmacol       Date:  1983-12       Impact factor: 3.765

9.  Coexistence of beta 1- and beta 2-adrenoceptors in the rabbit heart: quantitative analysis of the regional distribution by (-)-3H-dihydroalprenolol binding.

Authors:  O E Brodde; F J Leifert; H J Krehl
Journal:  J Cardiovasc Pharmacol       Date:  1982 Jan-Feb       Impact factor: 3.105

10.  Coexistence of beta 1- and beta 2-adrenoceptors in human right atrium. Direct identification by (+/-)-[125I]iodocyanopindolol binding.

Authors:  O E Brodde; K Karad; H R Zerkowski; N Rohm; J C Reidemeister
Journal:  Circ Res       Date:  1983-12       Impact factor: 17.367

View more
  22 in total

1.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects.

Authors:  D K Rohrer; K H Desai; J R Jasper; M E Stevens; D P Regula; G S Barsh; D Bernstein; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.

Authors:  B F Buxton; C R Jones; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

3.  Microfluidic heart on a chip for higher throughput pharmacological studies.

Authors:  Ashutosh Agarwal; Josue Adrian Goss; Alexander Cho; Megan Laura McCain; Kevin Kit Parker
Journal:  Lab Chip       Date:  2013-09-21       Impact factor: 6.799

4.  Binding of beta 1-adrenoceptor antagonist [3H]CGP 26505 in rat cerebral cortex and sinus atrial node.

Authors:  G Chiellini; G Giannaccini; C Martini; A Lucacchini
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

5.  Desensitization and functional antagonism by beta-adrenoceptor and muscarinic receptor agonists, respectively: a comparison with receptor alkylation for calculation of apparent agonist affinity.

Authors:  R M Eglen; W W Montgomery; R L Whiting
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

6.  Extent of beta 1- and beta 2-receptor occupancy in plasma assesses the antagonist activity of metoprolol, pindolol, and propranolol in the elderly.

Authors:  T Kaila; E Iisalo; A Lehtonen; H Saarimaa
Journal:  Cardiovasc Drugs Ther       Date:  1993-12       Impact factor: 3.727

7.  Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion.

Authors:  L McMartin; R J Summers
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

8.  Cardiac ventricular beta 2-adrenoceptors in guinea-pigs and rats are localized on the coronary endothelium.

Authors:  M Freissmuth; V Hausleithner; S Nees; M Böck; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

9.  Pre- and postganglionic stimulation-induced noradrenaline overflow is markedly facilitated by a prejunctional beta 2-adrenoceptor-mediated control mechanism in the pithed rat.

Authors:  V I Tarizzo; R P Coppes; C Dahlöf; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-06       Impact factor: 3.000

10.  Evidence for a cooperation between adenosine A2 receptors and beta 1-adrenoceptors on cardiac automaticity in the isolated right ventricle of the rat.

Authors:  J Hernandez; F Pinto; M A Figueira; J A Riberio
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.